ArticleInterdisciplinary sciences, computational life sciences2021
RSCMDA: Prediction of Potential miRNA-Disease Associations Based on a Robust Similarity Constraint Learning Method.
Article in Interdisciplinary sciences, computational life sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
With the rapid development of biotechnology and computer technology, increasing studies have shown that the occurrence of many diseases in the human body is closely related to the dysfunction of miRNA, and the relationship between them has become a new research hotspot. Exploring disease-related miRNAs information provides a new perspective for understanding the etiology and pathogenesis of diseases. In this study, we proposed a new method based on similarity constrained learning (RSCMDA) to infer disease-associated miRNAs. Considering the problems of noise and incomplete information in current biological datasets, we designed a new framework RSCMDA, which can learn a new disease similarity network and miRNA similarity network based on the existing biological information, and then update the predicted miRNA-disease associations using robust similarity constraint learning method. Consequently, the AUC scores obtained in the global and local cross-validation of RSCMDA are 0.9465 and 0.8494, respectively, which are superior to the other methods. Besides, the prediction performance of RSCMDA is further confirmed by the case study on lung Neoplasms, because 94% of the top 50 miRNAs predicted by the RSCMDA method are confirmed from the existing biological databases or research results. All the results show that RSCMDA is a reliable and effective framework, which can be used as new technology to explore the relationship between miRNA and disease.
Indexed as
Identifiers
34247324What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.